Sophia Genetics P/E 2025

Sophia Genetics Aktienanalyse

What does Sophia Genetics do?

Sophia Genetics SA is a Swiss company that was founded in 2011. The idea behind it was to improve genome sequencing and data analysis in order to make faster and more precise medical diagnoses. Sophia Genetics has since become a leading provider of artificial intelligence and data analysis in the medical field. The business model of Sophia Genetics is based on providing doctors and medical facilities with corresponding data analysis tools and platforms. Sophia Genetics' algorithms help to identify genetic anomalies and develop personalized therapies. This personalized medicine aims to improve healthcare. Sophia Genetics is divided into various sectors. The core sectors include oncology, pediatrics, cardiology, and neurology. In these specialized fields, Sophia Genetics' platforms and tools are used to optimize genome sequencing and data analysis, thus enabling faster and more precise diagnoses. The company offers a variety of products that help doctors and medical facilities create successful diagnoses and therapies. Sophia Genetics' flagship product is the Sophia Artificial Intelligence (AI) platform. This platform is used by doctors, clinics, and research institutions to analyze complex data and identify the genetic causes of diseases. The Sophia AI platform provides fast, precise, and secure genome sequencing and data analysis. Sophia Genetics also offers the Sophia DDM system. The DDM system is a cloud-based data exchange system that provides doctors and medical facilities with a secure way to exchange confidential medical data. The system also allows for the collection and analysis of information about diseases and disease progression in the population, in order to enable better healthcare. Another important product of Sophia Genetics is the Sophia Hereditary Cancer Solution. This product helps in the early detection of hereditary cancer. The Sophia Hereditary Cancer Solution provides fast and precise genetic diagnostics to identify family members at increased risk of cancer and take appropriate measures. Another product of Sophia Genetics is Sophia Radiomics. This software uses artificial intelligence and machine learning to detect and characterize diseases based on X-ray and CT scans. By analyzing large amounts of data, the Sophia Radiomics software can assist doctors in making more precise diagnoses and better treatment decisions. Sophia Genetics relies on close collaboration with medical facilities and research institutions worldwide. The company now has customers in over 60 countries and is a partner to more than 1,000 hospitals worldwide. Sophia Genetics' platforms and tools have already helped many people to be diagnosed and treated faster and more accurately. Overall, Sophia Genetics is an innovative company that has revolutionized medical diagnostics. With its advanced platforms and tools, the company provides doctors and medical facilities with an excellent opportunity to develop personalized therapies and enable better healthcare. Please write only the answer in the output. Sophia Genetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Sophia Genetics's P/E Ratio

The Price to Earnings (P/E) Ratio of Sophia Genetics is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Sophia Genetics's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Sophia Genetics is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Sophia Genetics’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Sophia Genetics stock

What is the price-to-earnings ratio of Sophia Genetics?

The price-earnings ratio of Sophia Genetics is currently -4.94.

How has the price-earnings ratio of Sophia Genetics changed compared to last year?

The price-to-earnings ratio of Sophia Genetics has increased by -12.1% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Sophia Genetics high compared to other companies?

Yes, the price-to-earnings ratio of Sophia Genetics is high compared to other companies.

How does an increase in the price-earnings ratio of Sophia Genetics affect the company?

An increase in the price-earnings ratio of Sophia Genetics would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Sophia Genetics affect the company?

A decrease in the price-earnings ratio of Sophia Genetics would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Sophia Genetics?

Some factors that influence the price-earnings ratio of Sophia Genetics are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Sophia Genetics pay?

Over the past 12 months, Sophia Genetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sophia Genetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Sophia Genetics?

The current dividend yield of Sophia Genetics is .

When does Sophia Genetics pay dividends?

Sophia Genetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sophia Genetics?

Sophia Genetics paid dividends every year for the past 0 years.

What is the dividend of Sophia Genetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sophia Genetics located?

Sophia Genetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sophia Genetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sophia Genetics from 1/28/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/28/2025.

When did Sophia Genetics pay the last dividend?

The last dividend was paid out on 1/28/2025.

What was the dividend of Sophia Genetics in the year 2024?

In the year 2024, Sophia Genetics distributed 0 USD as dividends.

In which currency does Sophia Genetics pay out the dividend?

The dividends of Sophia Genetics are distributed in USD.